dengu
mosquitoborn
arbovir
infect
endem
tropic
subtrop
countri
elev
liver
enzym
aspart
aminotransferas
ast
alanin
aminotransferas
alt
common
acut
dengu
ill
occur
dengu
patient
peak
convalesc
period
ill
day
dengueendem
countri
dengu
import
caus
acut
viral
hepat
elev
ast
alt
level
associ
bleed
dengu
hemorrhag
fever
dhf
liver
failur
recogn
complic
unusu
manifest
dengu
occur
infrequ
patient
taiwan
patient
vietnam
malaysia
pediatr
dhf
patient
develop
liver
failur
die
rest
recov
complet
singapor
ast
alt
level
independ
predictor
dhf
adult
dengu
patient
world
health
organ
revis
dengu
guidelin
propos
sever
organ
impair
one
categori
sever
dengu
addit
sever
plasma
leakag
sever
bleed
sever
liver
involv
defin
ast
unitslit
ul
taiwan
ast
time
upper
limit
normal
uln
occur
dengu
patient
brazil
occur
cohort
studi
aim
evalu
clinic
relev
elev
ast
alt
level
correl
liver
aminotransferas
level
dengu
sever
accord
classif
laboratoryconfirm
dengu
patient
identifi
hospit
microbiolog
databas
treat
use
standard
dengu
clinic
care
path
depart
infecti
diseas
tan
tock
seng
hospit
ttsh
singapor
retrospect
review
demograph
serial
clinic
laboratori
radiolog
treatment
outcom
data
case
posit
realtim
polymeras
chain
reaction
pcr
includ
patient
posit
dengu
serolog
subgroup
analys
pair
sera
etiolog
elev
ast
alt
could
exclud
without
extens
evalu
case
categor
use
serial
clinic
laboratori
data
entir
clinic
cours
dengu
fever
df
dhf
dengu
shock
syndrom
dss
use
classif
dengu
fever
classif
requir
fever
least
two
follow
headach
eye
pain
myalgia
arthralgia
rash
bleed
leukopenia
dengu
hemorrhag
fever
requir
follow
fever
platelet
count
bleed
plasma
leakag
dengu
shock
syndrom
case
dhf
either
tachycardia
puls
pressur
mmhg
systol
blood
pressur
mmhg
case
also
categor
dengu
without
warn
sign
ws
dengu
ws
sever
dengu
use
classif
dengu
requir
fever
two
follow
nausea
vomit
rash
ach
pain
leukopenia
warn
sign
warn
sign
includ
abdomin
pain
tender
persist
vomit
clinic
fluid
accumul
mucos
bleed
lethargi
restless
hepatomegali
hematocrit
rise
rapid
drop
platelet
count
modifi
warn
sign
rise
hematocrit
concurr
rapid
drop
platelet
count
quantifi
hematocrit
concurr
platelet
count
shown
correl
significantli
dengu
death
adult
dengu
death
studi
sever
dengu
includ
sever
plasma
leakag
sever
bleed
sever
organ
impair
perform
subgroup
analysi
median
maximum
ast
alt
valu
stratifi
febril
day
ill
critic
day
convalesc
day
phase
defin
compar
across
dengu
sever
classif
accord
exclud
sever
dengu
due
isol
elev
ast
ul
definit
sever
dengu
outcom
would
confound
assess
relev
ast
alt
level
defin
dengu
sever
patient
astalt
taken
present
throughout
hospit
physician
discret
maximum
ast
alt
valu
record
median
day
ill
interquartil
rang
iqr
day
use
analysi
preexist
liver
diseas
exclud
ttsh
uln
ast
ul
alt
ul
male
ul
femal
assess
clinic
relev
elev
ast
alt
level
use
four
liver
failur
acut
liver
failur
two
determin
prognosi
chronic
liver
diseas
american
associ
studi
liver
diseas
aasld
recommend
defin
acut
liver
failur
patient
intern
normal
ratio
inr
degre
alter
mental
statu
ill
week
durat
without
preexist
cirrhosi
king
colleg
criteria
assess
prognos
acut
liver
failur
criteria
prothrombin
time
second
follow
age
year
prothrombin
time
second
serum
bilirubin
mgdl
time
jaundic
encephalopathi
day
model
endstag
liver
diseas
meld
determin
threemonth
mortal
base
follow
formula
log
serum
bilirubin
mgdl
log
inr
log
serum
creatinin
mgdl
childpugh
criteria
includ
assess
degre
ascit
serum
bilirubin
albumin
prothrombin
time
encephalopathi
determin
one
twoyear
surviv
mannwhitney
u
kruskalw
test
use
determin
statist
signific
continu
variabl
chisquar
fisher
exact
test
categor
variabl
statist
test
conduct
level
signific
receiv
oper
characterist
roc
curv
show
area
curv
auc
gener
determin
discriminatori
perform
aminotransferas
valu
statist
analys
perform
use
stata
stata
corp
colleg
station
tx
retrospect
studi
involv
data
collect
medic
record
patient
data
anonym
analysi
studi
approv
institut
review
board
nation
healthcar
group
singapor
dsrb
overal
ast
uln
alt
uln
seven
patient
sever
dengu
accord
criteria
concurr
ast
ul
three
addit
patient
sever
dengu
due
ast
ul
former
seven
patient
sever
plasma
leakag
sever
bleed
none
sever
organ
impair
isol
ast
ul
among
patient
admit
icu
ast
alt
valu
uln
ul
patient
cohort
develop
acut
liver
failur
aasld
king
colleg
criteria
childpugh
score
belong
childpugh
class
c
meld
score
predict
threemonth
mortal
identifi
patient
cohort
patient
two
patient
childpugh
class
c
also
predict
threemonth
mortal
use
meld
score
dss
sever
dengu
median
ast
alt
valu
dengu
without
warn
sign
dengu
warn
sign
sever
dengu
tabl
ul
ul
ul
respect
p
median
alt
valu
ul
ul
ul
p
tabl
show
median
ast
alt
valu
patient
df
dhf
dss
median
ast
valu
categori
ul
ul
ul
respect
p
median
alt
valu
ul
ul
ul
p
separ
analysi
serologyposit
cohort
n
median
ast
valu
dengu
without
ws
dengu
ws
sever
dengu
ul
ul
ul
p
median
alt
valu
ul
ul
ul
p
patient
df
dhf
dss
median
ast
valu
ul
ul
ul
p
median
alt
valu
ul
ul
ul
p
hemorrhag
fever
higher
ratio
correl
diseas
fatal
pcrposit
cohort
median
ratio
df
dhf
dss
p
dengu
without
ws
dengu
ws
sever
dengu
p
respect
major
patient
maximum
ast
alt
valu
record
febril
n
critic
n
phase
acut
dengu
ill
dengu
sever
classif
median
ast
alt
valu
significantli
higher
sever
dengu
compar
dengu
without
warn
sign
febril
critic
phase
convalesc
phase
tabl
classif
median
ast
alt
valu
significantli
higher
dhf
versu
df
dss
febril
phase
critic
convalesc
phase
tabl
order
determin
reliabl
ast
alt
valu
defin
dengu
sever
roc
curv
ast
alt
sever
dengu
exclud
isol
transamin
determin
figur
auc
ast
confid
interv
ci
alt
ci
demonstr
ast
alt
level
insuffici
differenti
among
dengu
classif
also
poorli
discriminatori
df
dhf
area
curv
auc
ast
alt
ci
ci
respect
figur
serologyposit
cohort
auc
valu
ast
alt
differenti
df
dhf
auc
valu
sever
nonsever
dengu
ast
alt
respect
box
plot
figur
distribut
ast
valu
show
consider
overlap
among
liver
enzym
valu
dengu
without
warn
sign
sever
dengu
extrem
outlier
cohort
ast
ul
includ
plot
figur
show
overlap
ast
valu
among
df
dhf
similarli
consider
overlap
observ
alt
valu
patient
dengu
without
warn
sign
sever
dengu
well
df
versu
dhf
data
shown
analysi
show
liver
aminotransferas
level
associ
adequ
differenti
dengu
sever
although
median
ast
alt
valu
significantli
higher
dhfdss
versu
df
sever
dengu
versu
nonsever
dengu
ast
ul
notabl
none
develop
liver
failur
death
occur
patient
major
patient
recov
unev
lack
acut
liver
failur
studi
unusu
incid
acut
liver
failur
dengu
patient
studi
trung
kuo
largest
studi
date
report
acut
fulmin
hepat
contrast
adult
studi
noteworthi
dengueendem
countri
dengu
may
import
caus
acut
liver
failur
children
studi
shown
ast
alt
valu
differ
df
dhf
studi
support
ast
alt
independ
predictor
dhf
two
studi
singapor
found
liver
aminotransferas
level
significantli
elev
among
df
dhf
patient
survivor
nonsurvivor
dengu
univari
analysi
associ
lost
adjust
confound
multivari
analysi
trung
et
al
show
signific
differ
compar
febril
ill
dengu
without
plasma
leakag
dengu
plasma
leakag
without
shock
critic
convalesc
phase
ast
critic
phase
alt
made
novel
find
liver
aminotransferas
level
may
significantli
vari
accord
dengu
sever
febril
phase
dhf
classif
ast
alt
significantli
higher
febril
phase
compar
df
dss
sever
dengu
ast
alt
significantli
higher
febril
critic
phase
impact
coinfect
hepat
virus
concomit
hepatotox
drug
assess
retrospect
studi
although
exclud
known
liver
comorbid
kuo
et
al
found
hepat
b
c
increas
extent
liver
aminotransferas
elev
retrospect
adult
dengu
studi
taiwan
contrast
trung
et
al
found
hepat
b
coinfect
modestli
increas
alt
level
without
signific
clinic
impact
prospect
adult
dengu
studi
vietnam
tang
et
al
show
dengu
hepat
b
coinfect
patient
show
aberr
cytokin
secret
profil
compar
dengu
alon
singapor
seropreval
hepat
b
hepat
c
etiolog
elev
aminotransferas
level
acut
dengu
ill
unclear
sinc
ast
express
heart
skelet
muscl
red
blood
cell
kidney
brain
liver
alt
secret
primarili
liver
dengu
infect
caus
acut
damag
nonhepat
tissu
type
express
ast
rais
aminotransferas
level
may
entir
due
sever
liver
involv
therefor
possibl
patient
high
ast
level
also
like
classifi
sever
dengu
criteria
due
common
pathway
nonhepat
tissu
damag
even
though
associ
poorer
outcom
retrospect
studi
limit
aspart
alanin
aminotransferas
valu
track
accord
clinic
judgment
rather
regular
interv
ill
dengu
serotyp
data
patient
predomin
singapor
switch
serologyposit
case
includ
primari
analys
clinic
laboratori
use
rapid
diagnost
test
potenti
fals
posit
result
pair
sera
confirm
dengu
diagnosi
everi
patient
elev
ast
alt
comprehens
evalu
etiolog
viral
nonvir
hepat
although
serologyposit
case
present
later
ill
saw
differ
outcom
five
serologyposit
patient
requir
icu
admiss
versu
pcrposit
case
four
patient
die
serologyposit
cohort
versu
patient
among
pcrposit
case
howev
rel
data
accuraci
retrospect
studi
made
possibl
use
standard
dengu
clinic
care
path
anoth
limit
studi
rel
case
substanti
elev
liver
aminotransferas
level
time
sinc
cohort
compris
primarili
adult
addit
studi
pediatr
popul
use
confirm
find
patient
dhfdss
sever
dengu
earli
diagnosi
proper
manag
may
improv
outcom
patient
without
comorbid
howev
resourcelimit
countri
patient
sever
diseas
may
present
late
hospit
shock
without
organ
impair
time
admiss
studi
highlight
earli
diagnosi
proper
manag
dengu
patient
may
lead
excel
prognosi
without
organ
injuri
conclus
elev
aminotransferas
level
associ
dhfdss
sever
dengu
cohort
adult
patient
confirm
dengu
howev
threshold
valu
discrimin
df
dhf
sever
dengu
nonsever
dengu
